Our mission is to investigate the origins and biology of myeloid malignancies to impact the lives of the patients suffering from these disorders.

We do this by:

• Deep profiling patient samples longitudinally throughout disease to identify disruptions in the hematopoietic & immune systems.

• Establishing high fidelity in vivo models along the continuum from pre-malignant to malignant hematopoiesis.

• Using cutting edge approaches to model human disease ex vivo & in vitro. 

Current Projects

TET2 loss of FUnction and CLonal Hematopoiesis

Relevant Publications

Funding

We thank our funding sources for their generosity.